Farallon Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$213K	Buy	+4,000	New	+$213K	﹤0.01%	112
2023 Q4	–	Sell	-4,000	Closed	-$202K	–	157
2023 Q3	$202K	Buy	+4,000	New	+$202K	﹤0.01%	126
2019 Q3	–	Sell	-150,000	Closed	-$2.87M	–	99
2019 Q2	$2.87M	Buy	+150,000	New	+$2.87M	0.02%	96